Research Article

Effect of Hydroxychloroquine on the Retinal Layers: A Quantitative Evaluation with Spectral-Domain Optical Coherence Tomography

Table 1

Demographic characteristics and clinical data of users of hydroxychloroquine and controls.

Hydroxychloroquine usersControls value
Mean ± SDMean ± SD

Subjects ()5130
Eye ()5130
Sex (male/female)1/501/29
Age, y45.0 ± 13.1642.1 ± 14.30.35
IOP, mmHg15.95 ± 1.3216.17 ± 1.470.18
Axial length, mm23.03 ± 0.6623.03 ± 0.670.95
CCT, µm540.42 ± 32.90546.28 ± 3.780.25
BMI, kg/m225.17 ± 4.1224.64 ± 4.150.58
Cumulative dose, g648.41 ± 512.32NA
Duration of use, mo55.25 ± 41.27NA
Adjusted daily dose, mg/kg/d 8.75 ± 0.11NA
Diagnosis of patients, (%)
 Rheumatoid arthritis20 (39.2)NA
 Systemic lupus erythematosus19 (37.3)NA
 Sjögren’s syndrome12 (23.5)NA

IOP: intraocular pressure; CCT: central corneal thickness; BMI: body mass index; SD: standard deviation; value Student’s -test, < 0.05.